Resultado de búsqueda
17 de may. de 2024 · Going Above the Lows: A Fresh Look at Management of Severe Hypoglycemia in a Modern Diabetes World. Anne Peters, MD, summarizes key points regarding gaps, trends, and emerging treatment strategies to manage severe hypoglycemia in T1D and T2D. Authors: Anne L. Peters, MD. Log In to Start.
16 de may. de 2024 · Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus: Long-term Outcomes for Efficacy and Safety. Dr. Anne Peters discusses the data and offers her clinical perspective on the treatment of patients with type 2 diabetes with this drug class. Authors: Anne L. Peters, MD, CDE. Log In to Start.
Hace 6 días · Anne L. Peters, MD, is a professor of medicine at the University of Southern California (USC) Keck School of Medicine and director of the USC clinical diabetes programs.
16 de may. de 2024 · Asked to comment, Anne L. Peters, MD, director of the University of Southern California Westside Center for Diabetes, Los Angeles, told Medscape Medical News that she's "cautiously...
Hace 4 días · Experts in diabetes discuss the clinical relevance of recent safety data on DKA and bone fractures with SGLT2 inhibitors. Authors: Robert R. Henry, MD; Anne L. Peters, MD; Daniel Einhorn, MD. Log In to Start.
10 de may. de 2024 · Anne L. Peters, MD. Professor at the Keck School of Medicine; Director of the USC Clinical Diabetes Program, University of Southern California, Los Angeles, California
2 de may. de 2024 · Anne L. Peters, MD, talks about the difficulties in getting glucagon, when to use it in an emergency, and how it’s now easier than ever to teach loved ones how to use it. Educational content related to severe hypoglycemia is made possible with support from Xeris Pharmaceuticals , and Amphastar.
